Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?Zacks Investment Research • 03/04/24
Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to KnowZacks Investment Research • 03/01/24
Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ETGlobeNewsWire • 02/21/24
Aquestive Therapeutics (AQST) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 02/21/24
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual MeetingGlobeNewsWire • 02/15/24
Aquestive Therapeutics (AQST) Rises Higher Than Market: Key FactsZacks Investment Research • 02/15/24
Why Aquestive Therapeutics (AQST) Outpaced the Stock Market TodayZacks Investment Research • 02/09/24
Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's WhyZacks Investment Research • 02/03/24
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare ConferenceGlobeNewsWire • 01/30/24
Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 01/27/24
Aquestive Therapeutics (AQST) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 01/24/24
Aquestive Therapeutics: Anaphylm's Top-Line Data Could Reveal A Game-Changer In Q1Seeking Alpha • 01/19/24
Aquestive Therapeutics (AQST) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 01/18/24
Here's Why Aquestive Therapeutics (AQST) Fell More Than Broader MarketZacks Investment Research • 01/12/24
Aquestive Therapeutics Doses First Patient in Phase 3 Pivotal Clinical Study Evaluating Pharmacokinetics and Pharmacodynamics of Anaphylm™ (epinephrine) Sublingual FilmGlobeNewsWire • 12/05/23
Aquestive Therapeutics (AQST) Just Flashed Golden Cross Signal: Do You Buy?Zacks Investment Research • 11/29/23
Aquestive Therapeutics (AQST) Is Up 2.98% in One Week: What You Should KnowZacks Investment Research • 11/27/23